|
PCGF6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.24220000000419E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.635840E-04 |
| Normal-vs-Stage2 |
1.842170E-03 |
| Normal-vs-Stage3 |
2.842300E-03 |
| Normal-vs-Stage4 |
8.26510000000447E-05 |
| Stage1-vs-Stage2 |
6.356600E-01 |
| Stage1-vs-Stage3 |
8.009400E-01 |
| Stage1-vs-Stage4 |
2.087400E-01 |
| Stage2-vs-Stage3 |
5.607000E-01 |
| Stage2-vs-Stage4 |
5.362800E-01 |
| Stage3-vs-Stage4 |
2.004800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.95139999999272E-05 |
| Normal-vs-AfricanAmerican |
2.751800E-02 |
| Normal-vs-Asian |
4.877600E-03 |
| Caucasian-vs-AfricanAmerican |
6.893200E-01 |
| Caucasian-vs-Asian |
9.950400E-01 |
| AfricanAmerican-vs-Asian |
7.194400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.596300E-03 |
| Normal-vs-Female |
3.88439999999823E-05 |
| Male-vs-Female |
5.661800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.003600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.23700000004479E-06 |
| Normal-vs-Age(61-80Yrs) |
7.164600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.595600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.166200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.984000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.353400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.334970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.752200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.704800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.803600E-01 |
| Classical-VS-Follicular |
4.458000E-02 |
| Classical-VS-Other |
9.571400E-01 |
| Classical-VS-Normal |
3.535200E-03 |
| Tall-VS-Follicular |
6.522300E-02 |
| Tall-VS-Other |
6.446000E-01 |
| Tall-VS-Normal |
1.962590E-01 |
| Follicular-VS-Other |
5.707200E-01 |
| Follicular-VS-Normal |
6.04129999999259E-05 |
| Other-VS-Normal |
1.710010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8734099999973E-05 |
| Normal-vs-N1 |
1.524110E-03 |
| N0-vs-N1 |
9.313000E-01 |
|
|
